MERE LANE GROUP PRACTICE — All Prescriptions & Medications — Page 7
Practice Code: N82099 | LIVERPOOL, L5 0QW
Showing results 301-350 of 552
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ursodeoxycholic acid | 64 | 8,504 | £3.6K | -3.3% ▼ |
| Chlorhexidine gluconate | 64 | 18.7K | £143 | +191.4% ▲ |
| Dorzolamide | 63 | 1,040 | £519 | -24.2% ▼ |
| Testosterone | 62 | 5,569 | £2.5K | -18.7% ▼ |
| Dutasteride | 61 | 1,810 | £104 | +18.8% ▲ |
| Tolterodine | 61 | 2,856 | £464 | -59.0% ▼ |
| Bimatoprost | 61 | 588 | £533 | -59.0% ▼ |
| Glimepiride | 60 | 1,736 | £58 | -35.0% ▼ |
| Powder extensively hydrolysed formula (0913101) | 60 | 135.2K | £4.1K | -16.7% ▼ |
| Trazodone hydrochloride | 59 | 2,464 | £84 | -71.1% ▼ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 59 | 1,673 | £170 | -61.4% ▼ |
| Mometasone furoate | 59 | 4,570 | £419 | -55.9% ▼ |
| Permethrin | 59 | 4,068 | £931 | +56.6% ▲ |
| 59 | 59 | £67 | -73.2% ▼ | |
| Zolmitriptan | 55 | 450 | £2.0K | -15.3% ▼ |
| Glycerol | 54 | 843 | £128 | +53.9% ▲ |
| Biphasic isophane insulin | 54 | 392 | £1.6K | -51.6% ▼ |
| Canagliflozin | 54 | 1,510 | £1.9K | -62.4% ▼ |
| Tacrolimus | 54 | 2,010 | £1.6K | +0.1% vs avg |
| Colesevelam hydrochloride | 53 | 9,540 | £3.7K | +39.7% ▲ |
| Isophane insulin | 52 | 278 | £1.2K | -50.7% ▼ |
| Other individually formulated bought in preparations | 52 | 873 | £331 | +59.2% ▲ |
| Colchicine | 51 | 1,316 | £29 | -34.6% ▼ |
| 51 | 810 | £140 | +76.1% ▲ | |
| Amiodarone hydrochloride | 50 | 1,400 | £77 | -22.5% ▼ |
| Sodium fluoride | 50 | 5,712 | £650 | +50.7% ▲ |
| Cocois | 50 | 4,760 | £714 | +264.1% ▲ |
| Omega-3-acid ethyl esters | 49 | 4,088 | £2.0K | +131.9% ▲ |
| Desloratadine | 49 | 1,946 | £255 | +69.9% ▲ |
| Lisdexamfetamine dimesylate | 49 | 1,428 | £3.4K | -59.0% ▼ |
| Colestyramine | 47 | 2,954 | £1.2K | +63.2% ▲ |
| Terbutaline sulphate | 47 | 47 | £371 | -13.3% ▼ |
| Sodium feredetate | 47 | 11.1K | £319 | +64.1% ▲ |
| Exemestane | 46 | 1,317 | £255 | +41.6% ▲ |
| Hydrocortisone | 45 | 860 | £250 | -40.8% ▼ |
| Azathioprine | 45 | 2,716 | £82 | -58.5% ▼ |
| 44 | 3,921 | £503 | +117.6% ▲ | |
| Zinc oxide | 42 | 934 | £122 | +103.0% ▲ |
| Fluconazole | 42 | 357 | £78 | -45.7% ▼ |
| Bempedoic acid/Ezetimibe | 41 | 1,148 | £2.2K | -32.9% ▼ |
| Formoterol/glycopyrronium/budesonide | 41 | 41 | £1.7K | -31.9% ▼ |
| Alfuzosin hydrochloride | 41 | 1,228 | £465 | -42.7% ▼ |
| Etoricoxib | 41 | 1,148 | £287 | -49.1% ▼ |
| Adapalene and benzoyl peroxide | 41 | 1,875 | £818 | -23.2% ▼ |
| Terbinafine hydrochloride | 41 | 1,260 | £266 | +10.5% ▲ |
| 41 | 469 | £172 | -59.9% ▼ | |
| Neomycin sulfate | 40 | 615 | £78 | -32.5% ▼ |
| Zinc oxide | 40 | 13.0K | £385 | +98.9% ▲ |
| 40 | 40 | £6.9K | +12.0% ▲ | |
| Enoxaparin | 39 | 1,796 | £9.6K | +90.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.